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Castellano JM, Sanz G, Fernandez Ortiz A, Garrido E, Bansilal S, Fuster V.A Polypill Strategy to Improve Global Secondary Cardiovascular
Prevention: From Concept to Reality
J Am Coll Cardiol 2014;64:613–21
The ﬁrst sentence is the section titled ‘THE CNIC-FS-FERRER POLYPILL PROJECT: FROM CONCEPT TO
REALITY’ contained an error.
The Centro Nacional de Investigaciones Cardiovasculares (National Center for CV Investigations [CNIC]),
together with Ferrer Internacional, has developed a once-daily polypill for secondary CV prevention, con-
sisting of acetylsalicylic acid 100 mg, simvastatin 20 mg, and ramipril 2.5 mg/5 mg/10 mg (26).
should have been:
The Centro Nacional de Investigaciones Cardiovasculares (National Center for CV Investigations [CNIC]),
together with Ferrer Internacional, has developed a once-daily polypill for secondary CV prevention, con-
sisting of acetylsalicylic acid 100 mg, simvastatin 40 mg, and ramipril 2.5 mg/5 mg/10 mg (26).
The authors apologize for this error.http://dx.doi.org/10.1016/j.jacc.2014.08.007CORRECTION
Panza JA, Velazquez EJ, She L, Smith PK, Nicolau JC, Favaloro RR, Gradinac S, Chrzanowski L, Prabhakaran D,
Howlett JG, Jasinski M, Hill JA, Szwed H, Larbalestier R, Desvigne-Nickens P, Jones RH, Lee KL, Rouleau JLExtent of Coronary and Myocardial Disease and Beneﬁt
From Surgical Revascularization in Ischemic LV Dysfunction.
J Am Coll Cardiol 2014;12;64:553-61.
In the article title, the word “Ischemic” was inadvertently omitted.
It currently reads: Extent of Coronary and Myocardial Disease and Beneﬁt From Surgical Revascularization in
LV Dysfunction.
The correct title is printed below:
Extent of Coronary and Myocardial Disease and Beneﬁt From Surgical Revascularization in Ischemic
LV Dysfunction.
We apologize for this error.http://dx.doi.org/10.1016/j.jacc.2014.08.015
